연구성과로 돌아가기
2023 연구자 정보 (559 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Jin Seok (Kim, JS) |
Severance Hosp, Seoul, South Korea Yonsei Univ, Coll Med, Div Hematol, Severance Hosp,Dept Internal Med, Seoul, South Korea Yonsei Univ, Severance Hosp, Dept Internal Med, Div Hematol,Coll Med, Seoul, South Korea Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Div Hematol, Seoul, South Korea |
I-6927-2019 KIM, JIN |
0000-0001-8986-8436 KIM, JIN SEOK |
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) [JCR상위 28.4] Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY |
shglory@hanmail.net;HEMAKIM@yuhs.ac; ckmin@catholic.ac.kr;hseom@ncc.re.kr; |
||
|
Kim, Jung Jin (Kim, JJ) |
Catholic Univ Korea, Seoul St Marys Hosp, Dept Psychiat, Seoul St, Seoul, South Korea |
MTF-3196-2025 Kim, Jungjin |
|
[JCR상위 17.7] Predictors of full recovery in patients with early stage schizophrenia spectrum disorders | SCIE;SSCI | 17.7 | PSYCHIATRY | chungyc@jbnu.ac.kr; | ||
|
Kim, Kihyun (Kim, K) |
Samsung Med Ctr, Seoul, South Korea Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Sch Med,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea |
D-5175-2013 I-6927-2019 Kim, Kihyun KIM, JIN |
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 69.6] Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 28.4] Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study [JCR상위 35.6] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study [JCR상위 35.6] Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY HEMATOLOGY;ONCOLOGY ONCOLOGY |
jhmoon@knu.ac.kr;kihyunkimk@gmail.com; ckmin@catholic.ac.kr;hseom@ncc.re.kr; |
||
|
Kim, Mi Yeon (Kim, MY) |
Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Hwasun, South Korea Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Hawsun, Jeollanam Do, South Korea |
|
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY |
f0115@jnu.ac.kr; | ||
|
Kim, Mihee (Kim, M) |
Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Hawsun, Jeollanam Do, South Korea |
|
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY;ONCOLOGY HEMATOLOGY |
f0115@jnu.ac.kr; | ||
|
Kim, Seung-Hyun (Kim, SH) |
Korea Univ, Guro Hosp, Dept Psychiat, Coll Med, Seoul, South Korea Hanyang Univ, Dept Neurol, Coll Med, Seoul, South Korea Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea |
T-5133-2017 KIM, Seung Hyun |
0000-0001-9644-9598 KIM, Seung Hyun |
[JCR상위 17.7] Predictors of full recovery in patients with early stage schizophrenia spectrum disorders [JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum [JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum |
SCIE;SSCI SCIE |
1.5 |
PSYCHIATRY CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY CLINICAL NEUROLOGY;NEUROSCIENCES |
chungyc@jbnu.ac.kr; bjkim@skku.edu;sueh916@gmail.com; |
||
|
Kim, TaeHyung (Kim, T) |
Univ Toronto, Toronto, ON, Canada Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada Univ Toronto, Dept Comp Sci, Toronto, ON, Canada |
O-4252-2015 Kim, Tae |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
f0115@jnu.ac.kr; | ||
|
Koh, Young Il (Koh, YI) |
Seoul Natl Univ, Seoul, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | |||
|
Kook, Hoon (Kook, H) |
Chonnam Natl Univ, Hwasun Hosp, Dept Pediat, Med Sch, Gwangju, South Korea |
|
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
choihs1786@snubh.org;kanghj@snu.ac.kr; | ||
|
Lee, Eunyoung (Lee, E) |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | ||||
|
Lee, Je-Hwan (Lee, JH) |
Univ Ulsan, Coll Med, Seoul, South Korea Asan Med Ctr, Seoul, South Korea Univ Ulsan, Asan Med Ctr, Dept Hematol, Coll Med, Seoul, South Korea |
Q-1055-2018 Lee, Jeong-Hoon |
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 28.1] Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION MEDICINE, GENERAL & INTERNAL |
jhmoon@knu.ac.kr; | ||
|
Lee, Je-Jung (Lee, JJ) |
Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea Chonnam Natl Univ, Med Sch, Dept Hematol Oncol, Hwasun Hosp, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea Chonnam Natl Univ, Med Sch, Hwasun, Jeollanamdo, South Korea Kyungpook Natl Univ, Dept Hematol Oncol, Sch Med, Kyungpook Natl Univ Hosp, Daegu, South Korea Kyungpook Natl Univ, Dept Hematol Oncol, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea |
A-3892-2015 J-5603-2012 F-6974-2013 Lee, Sang-Jun Lee, Jong-Seok Lee, Jung-Hye |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia [JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 69.6] Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma [JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 35.6] Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY HEMATOLOGY;ONCOLOGY |
f0115@jnu.ac.kr; jhmoon@knu.ac.kr;kihyunkimk@gmail.com; shglory@hanmail.net;HEMAKIM@yuhs.ac; |
||
|
Lee, Kyu Young (Lee, KY) |
Eulji Univ, Eulji Gen Hosp, Dept Psychiat, Sch Med, Seoul, South Korea |
|
|
[JCR상위 17.7] Predictors of full recovery in patients with early stage schizophrenia spectrum disorders | SCIE;SSCI | 17.7 | PSYCHIATRY | chungyc@jbnu.ac.kr; | ||
|
Lee, Won-Sik (Lee, WS) |
Busan Paik Hosp, Busan, South Korea Inje Univ, Busan Paik Hosp, Busan, South Korea Inje Univ, Busan Paik Hosp, Dept Hematol & Oncol, Coll Med, Busan, South Korea |
J-5603-2012 Lee, Jong-Seok |
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) [JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) [JCR상위 28.1] Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study [JCR상위 49.0] A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE ESCI |
1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY MEDICINE, GENERAL & INTERNAL HEMATOLOGY |
shglory@hanmail.net;HEMAKIM@yuhs.ac; jhmoon@knu.ac.kr; kstwoh@skku.edu;drydh1685@hotmail.com; |
||
|
Lim, Eunmin (Lim, E) |
제1저자 | Kyungpook Natl Univ, Dept Chem Engn, Daegu 41566, South Korea |
|
|
[JCR상위 17.7] Microfluidic formation of surface nanodroplets using green deep eutectic solvents for liquid-liquid nanoextraction and controlled precipitation | SCIE | 17.7 | CHEMISTRY, PHYSICAL | jb.you@knu.ac.kr; |
페이지 이동: